Call for Papers:Vol.11 Issue.3

Submission
Last date		 28-Jun-2025
Acceptance Status In One Day
Paper Publish In Two Days
Submit ManuScript

News & Updates

Submit Article

Dear Authors, Article publish in our journal for Volume-11,Issue-3. For article submission on below link: Submit Manuscript


Join As Board

Dear Reviewer, You can join our Reviewer team without given any charges in our journal. Submit Details on below link: Join As Board


Paper Publication Charges

IJARIIE APP
Download Android App

For Authors

Archives

IJARIIE Board

Downloads

Android App

Download IJARIIE APP

Authors

Title: :  COVID-19 DRUGS-Investigational treatment
PaperId: :  14635
Published in:   International Journal Of Advance Research And Innovative Ideas In Education
Publisher:   IJARIIE
e-ISSN:   2395-4396
Volume/Issue:    Volume 7 Issue 3 2021
DUI:    16.0415/IJARIIE-14635
Licence: :   IJARIIE is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Author NameAuthor Institute
DARISHETTI HARITH KUMARSt.Peter’s Institute of Pharmaceutical Science,Hanmakonda,Warangal,Telangana,India.
NALLALA SANDHYASt.Peter’s Institute of Pharmaceutical Science,Hanmakonda,Warangal,Telangana,India.
RAFIKUL HOQUESt.Peter’s Institute of Pharmaceutical Science,Hanmakonda,Warangal,Telangana,India.
LUIT AZHAR ALISt.Peter’s Institute of Pharmaceutical Science,Hanmakonda,Warangal,Telangana,India.

Abstract

Pharmacy
Drug profile, efficacy, clinical research, metabolism, interactions, drug-receptor, inflammatory response, immune complexes
COVID-19 is the disease caused by an infection of the SARS-CoV-2 virus, first identified in the city of Wuhan, in China's Hubei province in December 2019. COVID-19 was previously known as 2019 Novel Coronavirus (2019-nCoV) respiratory disease before the World Health Organization (WHO) declared the official name as COVID-19 in February 2020.The SARS-CoV-2 virus belongs to the family of viruses called coronaviruses, which also includes the viruses that cause the common cold, and the viruses that cause more serious infections such as severe acute respiratory syndrome (SARS), which was caused by SARS-CoV in 2002, and Middle East respiratory syndrome (MERS), which was caused by MERS-CoV in 2012. Like the other coronaviruses, the SARS-CoV-2 virus primarily causes respiratory tract infections, and the severity of the COVID-19 disease can range from mild to fatal. Serious illness from the infection is caused by the onset of pneumonia and acute respiratory distress syndrome (ARDS). Currently, there are no FDA approved treatments for COVID-19, and the development of vaccines are still in pipeline.

Citations

Copy and paste a formatted citation or use one of the links to import into a bibliography manager and reference.

IJARIIE DARISHETTI HARITH KUMAR, NALLALA SANDHYA, RAFIKUL HOQUE, and LUIT AZHAR ALI. "COVID-19 DRUGS-Investigational treatment" International Journal Of Advance Research And Innovative Ideas In Education Volume 7 Issue 3 2021 Page 2501-2510
MLA DARISHETTI HARITH KUMAR, NALLALA SANDHYA, RAFIKUL HOQUE, and LUIT AZHAR ALI. "COVID-19 DRUGS-Investigational treatment." International Journal Of Advance Research And Innovative Ideas In Education 7.3(2021) : 2501-2510.
APA DARISHETTI HARITH KUMAR, NALLALA SANDHYA, RAFIKUL HOQUE, & LUIT AZHAR ALI. (2021). COVID-19 DRUGS-Investigational treatment. International Journal Of Advance Research And Innovative Ideas In Education, 7(3), 2501-2510.
Chicago DARISHETTI HARITH KUMAR, NALLALA SANDHYA, RAFIKUL HOQUE, and LUIT AZHAR ALI. "COVID-19 DRUGS-Investigational treatment." International Journal Of Advance Research And Innovative Ideas In Education 7, no. 3 (2021) : 2501-2510.
Oxford DARISHETTI HARITH KUMAR, NALLALA SANDHYA, RAFIKUL HOQUE, and LUIT AZHAR ALI. 'COVID-19 DRUGS-Investigational treatment', International Journal Of Advance Research And Innovative Ideas In Education, vol. 7, no. 3, 2021, p. 2501-2510. Available from IJARIIE, https://ijariie.com/AdminUploadPdf/COVID_19_DRUGS_Investigational_treatment_ijariie14635.pdf (Accessed : ).
Harvard DARISHETTI HARITH KUMAR, NALLALA SANDHYA, RAFIKUL HOQUE, and LUIT AZHAR ALI. (2021) 'COVID-19 DRUGS-Investigational treatment', International Journal Of Advance Research And Innovative Ideas In Education, 7(3), pp. 2501-2510IJARIIE [Online]. Available at: https://ijariie.com/AdminUploadPdf/COVID_19_DRUGS_Investigational_treatment_ijariie14635.pdf (Accessed : )
IEEE DARISHETTI HARITH KUMAR, NALLALA SANDHYA, RAFIKUL HOQUE, and LUIT AZHAR ALI, "COVID-19 DRUGS-Investigational treatment," International Journal Of Advance Research And Innovative Ideas In Education, vol. 7, no. 3, pp. 2501-2510, May-Jun 2021. [Online]. Available: https://ijariie.com/AdminUploadPdf/COVID_19_DRUGS_Investigational_treatment_ijariie14635.pdf [Accessed : ].
Turabian DARISHETTI HARITH KUMAR, NALLALA SANDHYA, RAFIKUL HOQUE, and LUIT AZHAR ALI. "COVID-19 DRUGS-Investigational treatment." International Journal Of Advance Research And Innovative Ideas In Education [Online]. volume 7 number 3 ().
Vancouver DARISHETTI HARITH KUMAR, NALLALA SANDHYA, RAFIKUL HOQUE, and LUIT AZHAR ALI. COVID-19 DRUGS-Investigational treatment. International Journal Of Advance Research And Innovative Ideas In Education [Internet]. 2021 [Cited : ]; 7(3) : 2501-2510. Available from: https://ijariie.com/AdminUploadPdf/COVID_19_DRUGS_Investigational_treatment_ijariie14635.pdf
BibTex EndNote RefMan RefWorks

Number Of Downloads



Save in Google Drive

Similar-Paper

TitleArea of ResearchAuther NameAction
Herbal Extract-Based Aquasomal Formulations: A New Avenue in Antifungal TreatmentMaster of pharmacy (Quality Assurance)ROHINI SANJAY SONAR Download
Chronic Liver Disease: New Targets and MechanismsPharmacyEmmanuela John Sima Download
Non-Pharmacological Interventions for ADHD: A Review of Behavioral, Cognitive, and Social StrategiesPharmacy Jayeeta Goswami Download
Repurposing of Statin as an robusting approach to treat Microbial infectionPharmacyMamta Download
ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) IN PEDIATRICSPHARMACYQureshi Abdul Mabud Download
The Role of Biomarkers in the Diagnosis and Treatment of DiseasesMasters of Pharmacy Abhay Verma, Download
Development and Evaluation of Atenolol tablet by using Tamarind Kernel Powder as a Natural DisintegrantPharmacyKunal D. Nikam Download
CASE REPORT ON P3L3 WITH PROCIDENTIA WITH LUMBAR SPONDYLOSISPHARMACYKEERTHANA.MM Download
FUROSEMIDE INDUCED HYPOKALEMIAPHARMACYBHAGYASHREE T Download
CASE REPORT ON BRONCHOPNEUMONIAPHARMACYDR .Raksha B H Download
BAKUCHIOL: “THE PLANT-BASED POWERHOUSE FOR YOUTHFUL SKIN’’PharmacyPrakash .P .Muleva Download
The Study of Etiology, Manifestation, Diagnosis and Treatment of MONKEY-POXPHARMACYMELAM.YESURATNAM Download
Analytical method development and validation of Anagliptin by RP-HPLCpharmacy (Quality Assurance)Gaurav B. Kokane Download
Intraocular Lens Implantation: A Review of Current Trends, Challenges, and Future Directions.Clinical PharmacyG. Roshini Raj Download
A Review on Newly Invented Drug Rapiblyk: Used for treatment of Supraventricular TachycardiaPharmacyMr. Shubham B Mandhare Download
12